Showing results (81-90 of 221) with videos related to
Sort By:
Pageof 23
Human Immunology|October 3, 2018
Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 496 adults from San Diego, California, USAEugene Moore, Alba Grifoni, Daniela Weiskopf, et al.Cell Reports|March 12, 2025
Distinct features of a peripheral T helper subset that drives the B cell response in dengue virus infectionAsgar Ansari, Shilpa Sachan, Jatin Ahuja, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2010
Molecular determinants of T cell epitope recognition to the common Timothy grass allergenCarla Oseroff, John Sidney, Maya F Kotturi, et al.Viruses|January 22, 2022
A Population of CD4<sup>+</sup>CD8<sup>+</sup> Double-Positive T Cells Associated with Risk of Plasma Leakage in Dengue Viral InfectionEsther Dawen Yu, Hao Wang, Ricardo da Silva Antunes, et al.Cell|October 23, 2020
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4<sup>+</sup> T Cells in COVID-19Benjamin J Meckiff, Ciro Ramírez-Suástegui, Vicente Fajardo, et al.PLOS Global Public Health|July 16, 2024
Identifying the strains of dengue circulating in the western province of Sri Lanka during 2019-2022Harshi Abeygoonawardena, Kanchana Dassanayake, Jayani Kariyawasam, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2011
Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine designDaniela Weiskopf, Lauren E Yauch, Michael A Angelo, et al.Cell Reports. Medicine|May 21, 2025
Chikungunya virus-specific CD4<sup>+</sup> T cells are associated with chronic chikungunya viral arthritic disease in humansRimjhim Agarwal, James Chang, Fernanda H Côrtes, et al.Ebiomedicine|May 26, 2022
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trialZoltán Bánki, Jose Mateus, Annika Rössler, et al.PLOS Global Public Health|August 16, 2023
Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot studyAnnemarie Namuniina, Enoch S Muyanja, Victoria M Biribawa, et al.Pageof 23